ICU Medical, Inc.ICUINASDAQ
LOADING
|||
Year-over-year research & development expense growth
| Period | Value |
|---|---|
| Q3 2025 | -2.82% |
| Q2 2025 | -6.11% |
| Q1 2025 | 4.19% |
| Q4 2024 | 6.31% |
| Q3 2024 | -10.10% |
| Q2 2024 | 7.09% |
| Q1 2024 | -2.54% |
| Q4 2023 | 7.38% |
| Q3 2023 | -6.42% |
| Q2 2023 | 12.86% |
| Q1 2023 | -15.72% |
| Q4 2022 | 1.48% |
| Q3 2022 | 2.41% |
| Q2 2022 | -5.48% |
| Q1 2022 | 81.31% |
| Q4 2021 | 7.58% |
| Q3 2021 | 7.49% |
| Q2 2021 | 6.31% |
| Q1 2021 | -9.22% |
| Q4 2020 | 16.50% |
| Q3 2020 | -1.49% |
| Q2 2020 | -4.35% |
| Q1 2020 | -14.63% |
| Q4 2019 | 4.87% |
| Q3 2019 | 7.17% |
| Q2 2019 | -12.66% |
| Q1 2019 | -5.19% |
| Q4 2018 | 2.61% |
| Q3 2018 | -2.90% |
| Q2 2018 | 7.86% |
| Q1 2018 | -9.30% |
| Q4 2017 | 8.67% |
| Q3 2017 | -1.53% |
| Q2 2017 | 11.39% |
| Q1 2017 | 338.62% |
| Q4 2016 | -27.29% |
| Q3 2016 | 9.35% |
| Q2 2016 | 0.75% |
| Q1 2016 | -18.34% |
| Q4 2015 | -4.02% |